StimuSIL is a medical device company focusing on photobiomodulation with multiple indications in dermatology and aesthetics.
StimuSIL has raised $600K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
StimuSIL's investors include The Net street.
StimuSIL is headquartered in Washington, United States.
StimuSIL is a medical device company focusing on photobiomodulation with multiple indications in dermatology and aesthetics.
StimuSIL is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"StimuSIL — Funding & Investors." VCBacked, March 6, 2025, https://www.vcbacked.co/company/stimusil. Accessed August 14, 2026.
VCBacked. (2025). StimuSIL — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/stimusil
{{cite web |title=StimuSIL — Funding & Investors |url=https://www.vcbacked.co/company/stimusil |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated